129 related articles for article (PubMed ID: 21401705)
1. Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma.
Yu SC; Chen SU; Lu W; Liu TY; Lin CW
Histopathology; 2011 May; 58(6):896-905. PubMed ID: 21401705
[TBL] [Abstract][Full Text] [Related]
2. Loss of CD19 expression in B-cell neoplasms.
Masir N; Marafioti T; Jones M; Natkunam Y; Rüdiger T; Hansmann ML; Mason DY
Histopathology; 2006 Feb; 48(3):239-46. PubMed ID: 16430470
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis on extramedullary plasmacytoma in the upper airway].
Ge S; Tan Z; Xie D; Yi Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 27(5):227-30. PubMed ID: 23729104
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
[TBL] [Abstract][Full Text] [Related]
5. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.
Zhi F; Chen X; Wang S; Xia X; Shi Y; Guan W; Shao N; Qu H; Yang C; Zhang Y; Wang Q; Wang R; Zen K; Zhang CY; Zhang J; Yang Y
Eur J Cancer; 2010 Jun; 46(9):1640-9. PubMed ID: 20219352
[TBL] [Abstract][Full Text] [Related]
6. [Solitary plasmacytoma of bone: a clinicopathologic, immunohistochemical and immunoglobulin gene rearrangement study].
Zuo Z; Liu WP; Tang Y; Bi CF; Wang XQ; Zhang WY; Yang QP; Zou LQ
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):177-82. PubMed ID: 20450765
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.
Ghodke K; Shet T; Epari S; Sengar M; Menon H; Gujral S
Ann Diagn Pathol; 2015 Jun; 19(3):117-23. PubMed ID: 25842207
[TBL] [Abstract][Full Text] [Related]
8. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus.
Aguilera NS; Kapadia SB; Nalesnik MA; Swerdlow SH
Mod Pathol; 1995 Jun; 8(5):503-8. PubMed ID: 7675768
[TBL] [Abstract][Full Text] [Related]
9. Clinical analysis of 40 multiple myeloma patients with extramedullary plasmacytoma of the head.
Sun WJ; Zhang JJ; An N; Shen M; Huang ZX; Li X
J Int Med Res; 2016 Dec; 44(6):1462-1473. PubMed ID: 28322099
[TBL] [Abstract][Full Text] [Related]
10. High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma.
Rasmussen T; Kastrup J; Knudsen LM; Johnsen HE
Br J Haematol; 1999 Apr; 105(1):265-7. PubMed ID: 10233390
[TBL] [Abstract][Full Text] [Related]
11. [Expression of miR-9 in B lymphocytes and B cell lymphomas cell lines and its significance].
Li F; Huang XP; Wang ZQ; Liu FR; Zhou XH; Zhong L; Wu ZQ; Han XQ; Zhu MG; Zhao T
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):249-53. PubMed ID: 21569708
[TBL] [Abstract][Full Text] [Related]
12. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
[TBL] [Abstract][Full Text] [Related]
13. [Solitary plasmacytomas of bone and extramedullary plasmacytomas].
Yang D; Fan S; Tao H
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):41-4. PubMed ID: 8732111
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck--hallmark of epithelial-mesenchymal transition.
Zidar N; Boštjančič E; Gale N; Kojc N; Poljak M; Glavač D; Cardesa A
Hum Pathol; 2011 Apr; 42(4):482-8. PubMed ID: 21237487
[TBL] [Abstract][Full Text] [Related]
15. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
[TBL] [Abstract][Full Text] [Related]
16. Late relapse of a light-chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem-cell transplantation.
Ozdemir E; Bayraktar M; Sökmensüer C; Kir KM; Kansu E
Clin Transplant; 2009; 23(6):981-4. PubMed ID: 19689453
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
Lin P; Owens R; Tricot G; Wilson CS
Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
[TBL] [Abstract][Full Text] [Related]
18. Contribution of microRNA 24-3p and Erk1/2 to interleukin-6-mediated plasma cell survival.
Gabler J; Wittmann J; Porstner M; Renz H; Jäck HM; Abram M; Zemlin M
Eur J Immunol; 2013 Nov; 43(11):3028-37. PubMed ID: 23934711
[TBL] [Abstract][Full Text] [Related]
19. [Refractory multiple myeloma preceded by extramedullary plasmacytoma of lymph node--a case report and review of the literature].
Ise M; Nakaseko C; Sakai C; Takagi T
Rinsho Ketsueki; 1999 Jun; 40(6):505-10. PubMed ID: 10422289
[TBL] [Abstract][Full Text] [Related]
20. CD31 expression in plasmacytic/plasmablastic lesions.
Plocharczyk E; Wakely PE
Ann Diagn Pathol; 2013 Dec; 17(6):498-501. PubMed ID: 24074836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]